COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804


Print ISSN:-2394-4781

Online ISSN:-2394-4994

CODEN : IJCACT

Current Issue

Year 2020

Volume: 7 , Issue: 1

  • Article highlights
  • Article tables
  • Article images

Article view: 156

Article download: 111

Jeevapriya and Selvakumar: Study on evaluating the effect of Intravenous dexmedetomidine on depth of anaesthesia in patients undergoing lower segment cesarean section under general Anaesthesia


Introduction

Being Aware during General Anaesthesia is the biggest problem which is on increasing trend on recent studies,1,2 in particular during cesarean section3,4,5 because of withdrawal of opioids, sedatives, using low concentration of nitrous oxide& volatiles due to sedativeeffect & respiratory depression in neonates, until delivery .

Dexmedetomidine, a highly selective α2 agonist which has sedative, analgesic & antisympathetic effect and produce conscious sedation without respiratory depression. Placental transfer and fetal metabolism of dexmedetomidine have been reported but there are no adverse effects on neonates, shown by apgar score.

In this study, dexmedetomidine is used to pr event awareness which was measured using BIS score & isolated forearm technique.6

Materials and Methods

After obtaining ethical committee approval, an informed written consent obtained from all participants. This study included 50 full term parturients in the age group 21-30 years who were posted for elective cesarean section for different indications under General Anaesthesia. They were divided into 2 groups by sealed enveloped technique to receive 1mcg/kg IV dexmedetomidine 10 minutes before induction (Group A) or to not receive dexmedetomidine, control group (Group B) (n=25). Patients with medical illness excluding PIH /severe renal, hepatic, cardiac illness, neurological disease, allergy to dexmedetomidine and fetal compromise were excluded from the study.

Demographic data were recorded including maternal age & body weight

For prophylaxis against aspiration, Inj. ranitidine 50 mg &Inj.perinorm 10mg i.v.were given 30 minutes before induction. Monitoring was done using ECG, NIBP, pulse oximetry, BIS monitor.

The person who supervised the anaesthesia ,explained the concept of study to patients and placed sphygmomanometer cuff around the Right arm of the patients after placing the cotton bandage and inflated it to 200 mm Hg immediately before induction. This technique isolated the Right sidearm from the effects of Neuromuscular blocking agents. Then the patient was presented with command, “open and close your Right hand”. This was done every thirty seconds throughout the procedure til extubation. The cuff was deflated every twenty minutes to prevent ischemic paralysis.

After three minutes of preoxygenation, after adequate premedication with Inj. Glyco 0.2mg, Rapid Sequence Induction performed with Inj.thiopentone 4-5 mg/kg and Inj.suxa 1-2mg/kg.

Cricoid pressure then applied andpatient intubated appropriate sized endotracheal tube. Anaesthesia was maintained with 50% N2 0 and 50% O2 and sevoflurane with concentration of 0.5 – 1 %, until delivery.

After delivery of the baby, Inj.fentanyl 100mcg IV & Inj.midazolam 0.3mg/kg given. Sevoflurane administration stopped at start of closure of subcutaneous and N2O was then stopped at start of closure of skin.

BIS values & Isolated forearm responses were monitored. Apgar score were also recorded.

Results

Age and weight statistics (Demographic) data showed no significant difference between two groups. (Table 1)

Table 1
Group a Group b ‘p’ value
Age 26.16±5.54 27.5±5.01 0.42
Weight 51.86±10.28 54.33±10.72 0.18

Demographic data distribution between the two groups A &B

Comparing awareness in both group, in Group A the BIS score was around 49-68 and in Group B BIS score was around 62-88, with statistically significant value of P< 0.05. BIS Scores recorded during various period of the procedure in both Groups A and B shown in Figure 1.

Chart 1

BIS values recorded during various period in both Groups A and B

https://s3-us-west-2.amazonaws.com/typeset-media-server/71c14e39-b03d-4de5-8386-fc020b48122cimage1.png

No statistical difference between both groups in Apgar score (P>0.05)(Table 2)

Chart 2

Apgar Score between two groups A & B

https://s3-us-west-2.amazonaws.com/typeset-media-server/71c14e39-b03d-4de5-8386-fc020b48122cimage2.png

Negative isolated arm response in Group A, positive response obtained in Group B.

Table 2
IFT Response
Group A 4(0.16%)
Group B 18(72%)
P value <0.05

Isolated forearm Test Response obtained in Group A & B

Haemodynamic variables recorded during the entire anaesthesia procedure in both groups shown in Figure 2,Figure 3.

Chart 3

Systolic BP variation recorded in Group A & B

https://s3-us-west-2.amazonaws.com/typeset-media-server/71c14e39-b03d-4de5-8386-fc020b48122cimage3.png

Chart 4

HR Variation recorded in Group A & B

https://s3-us-west-2.amazonaws.com/typeset-media-server/71c14e39-b03d-4de5-8386-fc020b48122cimage4.png

Discussion

In this study, it was found that dexmedetomidine succeeded significantly in aborting awareness & maintaining hemodynamic stability7,8 & didn’t affect the APGARscore .

Studies on the use of dexmedetomidine for cesarean section9,10,11 are sparse. The available literature Nosaiba K.EZ Z El-Arab, salama I . EI- Hawary, Ashraf E.El-Zeftawy, RebabM. Mohammed 2017 , 220.225 shows use of dexmedetomidine with median BIS of 50 & didn’t affect apgar score.

Dexmedetomidine, under the trade name Precedex among others, is an anxiety reducing, sedative, and also as an analgesic sometimes. Its is notable for its ability to produce sedation without producing much respiratory depression (unlike propofol, fentanyl and midazolam) and can provide cooperative or semi-arousable sedation.12

Dexmedetomidine excite the presynaptic α2 -AR, inhibit or reduce Norepinephrine release & stop pain signal transduction. It also excite postsynaptic α2 -AR, lead to hyperpolarisation of neural cell Membrane& inhibit Norepinephrine release & inhibit sympathetic activity. Dexmedetomidine excites the presynaptic α2 -AR of the nucleus ceruleus arousal response.

α2-Adrenergic Receptor agonists like dexmedetomidine produce clinical effects after binding to G-Protein-coupled α2 adrenergic receptors, of which there are three alpha subtypes (A, B, and C) with each having different physiological functions and pharmacological activities. These subtypes are found in peripheral, central, and autonomic nervous systems, as well as in major organs and blood vessels.12

Dexmedetomidine is d-enantiomer of medetomidine13 with highly selective alpha2 action (alpha2:alpha1=1600:1). Neither dexmedetomidine nor clonidine is totally selective for any of the α2receptor sub types, but dexmedetomidine seems to have increased α2Areceptor and α2C receptor affinity compared to clonidine.

Locus ceruleus of the brain stem is responsible for the sedative action, and spinal cord is the principal site for the analgesic action, both acting through α2A receptor.14 In the heart, the predominant action of α2 adrenergic receptor is a decrease in heart rate through blocking cardioaccelerator nerve through subtype 2A and through vagomimetic action. In the peripheral vascular tissues, there is sympatholytic induced vasodilatation and smooth muscle receptormediated vasoconstriction.

Finding out whether a patient is conscious or awake while undergoing general anesthesia pose a major problem.15 The limitations of current clinical methods to assess anesthetic adequacy have been well known. Mechanisms in the central nervous system that controlhigher functions likememory and consciousness may be anesthetized adequately, whereas spinal cord mechanisms that suppress movement to surgical stimulus may not be anaesthetised adequately. A direct method of evaluating consciousness is needed, rather than the current practice of monitoring hemodynamic changes or movement responses.

A machine or monitor that measures physiologic changes associated with the conscious state would be an improvement on current methods, which are dependent on responses that only indirectly reflect consciousness.

The bispectral monitoring system, an Electroencephalogram derived data was introduced for clinical use in October 1996, as a technique for measuring depth of anaesthesia16,17 induced by hypnotics and sedatives and as a guide for the administration of various drugs intraoperatively. Its use in clinical practice is increasing all over the world to prevent intraoperative awareness and is also recognised beyond the operating room to critical care units, accident and emergency units.

The isolated forearm technique, was originally described by Tunstall, in contrast to BIS detects the return of consciousness.18,19 The use of this technique to identify recovery of response, in response toverbal commandsalong with the BIS monitoring enabled study of the association between return of consciousness and a quantitative, measurement of anesthetic adequacy.

Conclusion

The study concluded that loading dose of IV dexmeditomedine 1mcg/kg is effective in aborting awareness without affecting APGAR score. Dexmedetomidine, when given as a pre-anaesthetic medication and intraoperative infusion, decreases stress response to various noxious stimuli and maintains haemodynamic stability.

Source of Funding

None.

Conflict of Interest

None.

References

1 

F Zand E Allahyary H R Tabatabaee Evaluation of the adequacy of general anesthesia in caesarean section by auditory evoked potential index : an observational studyActa Anaesth Taiwan2008461624

2 

G Lyons R Macdonald Awareness during caesarean sectionAnesth1991466264

3 

K Leslie A J Davidson Awareness during anesthesia: a problem without solutions?Minerva Anesthesiol201076624628

4 

P Bischoff I Rundshagen Awareness under general anesthesiaDtsch Arztebl Int201110817

5 

Whd Liu T A Thorp S G Graham A R Aitkenhead Incidence of awareness with recall during general anaesthesiaAnaesth199146435437

6 

F Zond SMR Hadavi A chohedri Survey on the adequacy of depth of anaesthesia with bispectral index and isolated forearm technique in elective Caesarean section under general anaesthesia with sevofluraneBJA2014112871878

7 

V M Keniya S Ladi R Naphade Dexmedetomidine attenuates sympathoadrenal response to tracheal intubation and reduces perioperative anaesthetic requirementIndian J Anaesth201155352357

8 

C R Patel S R Engineer B J Shah Effect of intravenous infusion of dexmedetomidine on perioperative haemodynamic changes and postoperative recovery: A study with entropy analysisIndian J Anaesth201256542546

9 

G Blaudszun A S Nair K Sriprakash Dexmedetomidine in pregnancy: Review of literature and possible useJ Obstetr Anaesth Crit Care2013333

10 

S A Abu-Halaweh A I Oweidi A-Ks M Zabalawi F Alkazaleh F Abu-Ali Comparative Evaluation of Remifentanil and Dexmedetomidine in General Anesthesia for Cesarean DeliveryEur J Anaesthesiol2009268687

11 

M M Neumann M B Davio M R Macknet Dexmedetomidine for awake fiberoptic intubation in a parturient with spinal muscular atrophy type III for cesarean deliveryInt J Obstet Anesth200918403407

12 

Kamibayashi T M Maze Clinical uses of alpha2 -adrenergic agonistsAnaesthesiol20009313451349

13 

J M Savola H Ruskoaho J Puurunen J S Salonen N T Krki Evidence for medetomidine as a selective and potent agonist at alpha 2-adrenoreceptorsJ Auton Pharmacol19866275284

14 

C Lysakowski Elia N M R Tramer Effect of Perioperative Systemic 2 Agonists on Postoperative Morphine Consumption and Pain Intensity: Systematic Review and Meta-analysis of Randomized Controlled Trials201211613121322

15 

Jones JG. London . Russell IF: Conscious awareness during general anesthesia, Depth of anesthesia, Baillire's Clinical AnesthesiologyBailliere Tindall1989511532

16 

M S Avidan L Zhang B A Burnside Anesthesia awareness and the bispectral indexN Engl J Med200835810971108

17 

P S Myles K Leslie J Mcneil A Forbes M T Chan Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlledtrialLancet200436317571763

18 

J L Breckenridge A R Aitkenhead Isolated forearm technique for detection of wakefulness during general anesthesiaBr J Anaesth198153665666

19 

Tunstall ME. Awareness, caesarean section and the isolated forearm techniqueAnaesth199045686



jats-html.xsl

© 2019 Published by Innovative Publication. This is an open access article under the CC BY-NC-ND license (creativecommons.org)